- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Policy Recommendations North Dakota
2020-21 Improvements and Recommendations
2021 was a year of growth for North Dakota’s patient registry as the population more than doubled over the number cited in our last report. Despite the growth, patients in North Dakota complained that a shortage of doctors willing to recommend cannabis has made access to the program difficult. The first of two pieces of legislation on medical cannabis that went into effect in 2021 may help the problem. HB 1213 which made some language changes to some statutory definitions, most notably making it easier to establish a “bona fide” relationship to receive a recommendation for medical cannabis from a medical provider. The bill also made a modification to the application fees for cannabis businesses by replacing a set fee with “fee not to exceed”. This is a move that could signal the state is willing to license more cannabis businesses which ASA would highly recommend; eight retailers is simply not adequate for a state the size of North Dakota and as the program continues to grow, it is likely to become an issue.
HB 1359 was the second piece of North Dakota legislation to go into effect in 2021. It made some minor rule changes for caregivers; raising the cap on the number of patients each caregiver may serve, as well as eliminating the application fee, and in some cases the background check. The bill also included a provision to expand the membership of the Medical Marijuana Advisory Board to include physicians and patients, though these new positions have yet to be filled.
In 2022, ASA recommends that lawmakers In South Dakota prioritize improving access to cannabis - a category where the state only scored 10% of available points. The state can do this by passing a law that would recognize out of state patient registrations, allow home cultivation for patients and caregivers, and give licensed retailers the option to offer delivery and curbside pickup.